These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 24196340)

  • 1. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical antifungal treatments for tinea cruris and tinea corporis.
    El-Gohary M; van Zuuren EJ; Fedorowicz Z; Burgess H; Doney L; Stuart B; Moore M; Little P
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009992. PubMed ID: 25090020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naftifine: A Topical Allylamine for Superficial Dermatophytosis.
    Trailokya AA; Shirsat AB; Madhu R; Shah B
    J Assoc Physicians India; 2023 May; 71(5):11-12. PubMed ID: 37355825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of topical antifungal therapy in dermatomycoses. A North American perspective.
    Gupta AK; Einarson TR; Summerbell RC; Shear NH
    Drugs; 1998 May; 55(5):645-74. PubMed ID: 9585862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
    Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Jul; 14(7):686-91. PubMed ID: 26151784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses.
    Monk JP; Brogden RN
    Drugs; 1991 Oct; 42(4):659-72. PubMed ID: 1723367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents.
    Ganzinger U; Stutz A; Petranyi G; Stephen A
    Acta Derm Venereol Suppl (Stockh); 1986; 121():155-60. PubMed ID: 3459341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical fenticonazole in dermatology and gynaecology: current role in therapy.
    Veraldi S; Milani R
    Drugs; 2008; 68(15):2183-94. PubMed ID: 18840006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of interdigital tinea pedis].
    Korting HC; Rychlik R; Pfeil B
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1819-24. PubMed ID: 12964099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
    Jegasothy BV; Pakes GE
    Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naftifine: a review.
    Gupta AK; Ryder JE; Cooper EA
    J Cutan Med Surg; 2008; 12(2):51-8. PubMed ID: 18346400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naftifine treatment of resistant dermatophytosis.
    Rosen T; Fischer M; Orengo I; Abuabara F
    Int J Dermatol; 1991 Aug; 30(8):590-2. PubMed ID: 1938060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the best way to treat tinea cruris?
    Nadalo D; Montoya C; Hunter-Smith D
    J Fam Pract; 2006 Mar; 55(3):256-8. PubMed ID: 16510062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Topical terbinafine. Reduction of duration of therapy for tinea pedis].
    Schmid-Wendtner MH; Korting H
    Hautarzt; 2008 Dec; 59(12):986-91. PubMed ID: 18987841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycological Considerations in the Topical Treatment of Superficial Fungal Infections.
    Rosen T
    J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s49-55. PubMed ID: 26885799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine].
    Albanese G; Giorgetti P; Santagostino L; Di Cintio R; Colombo MD
    G Ital Dermatol Venereol; 1989 May; 124(5):XXXIII-XXXVII. PubMed ID: 2620916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.